top of page


Scope law advises an institutional investor in its divestment in connection with Biognosys AG’s strategic partnership with Bruker Corporation.

Biognosys AG and Bruker Corporation (Nasdaq: BRKR) announced a strategic partnership, in which Bruker has made a majority-ownership investment in the ETH spin-off Biognosys. Financial details were not disclosed. Scope law’s client has, together with other investors, sold its shares to Bruker in a secondary transaction, and Bruker will make new primary investments in Biognosys.

Recent Posts

See All

M&A Transaction

Scope Law advises the seller on the sale of a day nursery business with several locations in Zurich to a larger Swiss corporate group specializing in the management of supplementary family care servic

M&A Transaction

Scope Law advises the seller on the sale of MCMmedsys AG (Solothurn, Switzerland) to Healthcare Holding Schweiz AG (Baar, Switzerland). MCMmedsys is one of the leading independent distributors of medi


For the third consecutive year, Scope Law has been ranked as one of the top Swiss law firms by the renowned business magazines BILANZ and PME. This year in a total of 11 practice areas, including Corp


bottom of page